Your browser doesn't support javascript.
loading
Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center.
Isaksson, Sofi; Hazem, Bassam; Jönsson, Mats; Reuterswärd, Christel; Karlsson, Anna; Griph, Håkan; Engleson, Jens; Oskarsdottir, Gudrun; Öhman, Ronny; Holm, Karolina; Rosengren, Frida; Annersten, Karin; Jönsson, Göran; Borg, Åke; Edsjö, Anders; Levéen, Per; Brunnström, Hans; Lindquist, Kajsa Ericson; Staaf, Johan; Planck, Maria.
Afiliação
  • Isaksson S; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Hazem B; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Jönsson M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Reuterswärd C; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Karlsson A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Griph H; Department of Respiratory Medicine, Skane University Hospital, Lund, Sweden.
  • Engleson J; Department of Oncology, Skane University Hospital, Lund, Sweden.
  • Oskarsdottir G; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Öhman R; Department of Respiratory Medicine, Skane University Hospital, Lund, Sweden.
  • Holm K; Department of Respiratory Medicine, Skane University Hospital, Lund, Sweden.
  • Rosengren F; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Annersten K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Jönsson G; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Edsjö A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Levéen P; Department of Pathology, Regional Laboratories Region Skane, Lund, Sweden.
  • Brunnström H; Department of Pathology, Regional Laboratories Region Skane, Lund, Sweden.
  • Lindquist KE; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Staaf J; Department of Pathology, Regional Laboratories Region Skane, Lund, Sweden.
  • Planck M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
JTO Clin Res Rep ; 1(1): 100013, 2020 Mar.
Article em En | MEDLINE | ID: mdl-34589915
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos